Department of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Med Mycol. 2010 Jun;48(4):580-8. doi: 10.3109/13693780903401682.
Surfactant protein D (SP-D) plays a central role in pulmonary innate immune responses to microbes and allergens, often enhancing clearance of inhaled material. Although SP-D functions during bacterial and viral infections are well established, much less is known about its possible roles during invasive fungal infections. Aspergillus fumigatus is a prominent fungal pathogen in immunocompromised individuals, and can cause allergic or invasive aspergillosis. SP-D has been shown to be protective against both of these disease modalities. The moieties present on the fungal surface responsible for SP-D binding remain largely unclear, although cell wall 1,3-beta-D-glucan is bound by SP-D in other fungal species. There is little information regarding the interaction of SP-D with A. fumigatus hyphae which are responsible for the invasive form of disease. Here, we show that SP-D binding to A. fumigatus hyphae is sensitive to the activity of the calcium-activated protein phosphatase calcineurin. Deletion of the catalytic subunit calcineurin A (DeltacnaA) or pharmacologic inhibition of calcineurin through FK506 abrogated SP-D binding. In contrast, SP-D binding to Cruptococcus neoformans was calcineurin-independent. Pharmacologic inhibition of A. fumigatus cell wall components by caspofungin (inhibits 1,3-beta-D-glucan synthesis) and nikkomycin Z (inhibits chitin synthesis) increased SP-D binding to the wild-type strain. In contrast, SP-D binding increased in the DeltacnaA strain only after nikkomycin Z treatment. We conclude that SP-D binding to A. fumigatus hyphae is calcineurin-sensitive, presumably as a consequence of calcineurin's role in regulating production of key cell wall binding partners, such as 1,3-beta-D-glucan. Elucidation of the interaction between lung innate immune factors and A. fumigatus could lead to the development of novel therapeutic interventions.
表面活性蛋白 D(SP-D)在肺部对微生物和过敏原的先天免疫反应中发挥核心作用,通常增强对吸入物质的清除。虽然 SP-D 在细菌和病毒感染期间的功能已经得到很好的证实,但对其在侵袭性真菌感染期间的可能作用知之甚少。烟曲霉是免疫功能低下个体中的一种重要真菌病原体,可引起过敏或侵袭性曲霉病。SP-D 已被证明对这两种疾病模式都具有保护作用。尽管在其他真菌物种中,SP-D 结合细胞壁 1,3-β-D-葡聚糖,但负责 SP-D 结合的真菌表面的部分仍然很大程度上不清楚。关于 SP-D 与负责侵袭性疾病的烟曲霉菌丝体相互作用的信息很少。在这里,我们表明 SP-D 与烟曲霉菌丝体的结合对钙激活蛋白磷酸酶钙调神经磷酸酶的活性敏感。钙调神经磷酸酶 A(DeltacnaA)的缺失或 FK506 通过抑制钙调神经磷酸酶来破坏 SP-D 结合。相比之下,SP-D 与新型隐球菌的结合不受钙调神经磷酸酶的影响。通过卡泊芬净(抑制 1,3-β-D-葡聚糖合成)和 nikkomycin Z(抑制几丁质合成)抑制烟曲霉细胞壁成分对细胞的药理抑制增加了对野生型菌株的 SP-D 结合。相比之下,只有在用 nikkomycin Z 处理后,DeltacnaA 菌株中的 SP-D 结合才会增加。我们得出结论,SP-D 与烟曲霉菌丝体的结合对钙调神经磷酸酶敏感,可能是钙调神经磷酸酶在调节关键细胞壁结合伙伴(如 1,3-β-D-葡聚糖)产生中的作用所致。阐明肺部先天免疫因子与烟曲霉之间的相互作用可能导致新的治疗干预措施的发展。